Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Establishment of Four Wholly Owned Subsidiaries
Lexaria’s technology changes the manner in which edible cannabinoids enter the body The company out-licenses its DehydraTECH drug delivery platform Lexaria recently announced the creation of four wholly owned subsidiaries A research-driven company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is the only company globally that has been awarded a patent for the improved delivery of all cannabinoids. It has developed and out-licenses its DehydraTECH technology – a drug delivery platform. This technology is a complementary layer that works with other research and development being conducted on cannabinoids and, as such, is an enabling technology, not a competing one. Lexaria…